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Abstract
Background: Most mitochondrial mRNAs in Trypanosoma brucei require RNA editing for maturation and translation. The
edited RNAs primarily encode proteins of the oxidative phosphorylation system. These parasites undergo extensive changes
in energy metabolism between the insect and bloodstream stages which are mirrored by alterations in RNA editing. Two U-
specific exonucleases, KREX1 and KREX2, are both present in protein complexes (editosomes) that catalyze RNA editing but
the relative roles of each protein are not known.
Methodology/Principal Findings: The requirement for KREX2 for RNA editing in vivo was assessed in both procyclic (insect)
and bloodstream form parasites by methods that use homologous recombination for gene elimination. These studies
resulted in null mutant cells in which both alleles were eliminated. The viability of these cells demonstrates that KREX2 is not
essential in either life cycle stage, despite certain defects in RNA editing in vivo. Furthermore, editosomes isolated from
KREX2 null cells require KREX1 for in vitro U-specific exonuclease activity.
Conclusions: KREX2 is a U-specific exonuclease that is dispensable for RNA editing in vivo in T. brucei BFs and PFs. This result
suggests that the U deletion activity, which is required for RNA editing, is primarily mediated in vivo by KREX1 which is
normally found associated with only one type of editosome. The retention of the KREX2 gene implies a non-essential role or
a role that is essential in other life cycle stages or conditions.
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Introduction
The mitochondrial genome of Trypanosoma brucei encodes 12
genes whose mRNAs undergo post-transcriptional editing that
dramatically changes their protein coding sequences [1–3]. Using
information provided by guide RNA (gRNA) templates, uridine
(U) nucleotides are either inserted or deleted at specific editing sites
within these RNAs. The extent of editing varies between RNAs,
with some RNAs undergoing insertion and deletion of hundreds
and tens of Us, respectively. Multiple editing sites are specified by
a single gRNA and multiple gRNAs are used in the editing of most
mRNAs. This RNA editing is catalyzed by protein complexes
called editosomes that contain endoribonuclease, 39 Terminal
Uridylyl-Transferase (TUTase), 39 U-specific exoribonuclease
(exoUase), and RNA ligase activities.
Three compositionally distinct ,20S editosomes have been
identified, each containing a common set of 12 proteins, and a
mutually exclusive set of 2 or 3 proteins typified by one of three
kinetoplastid RNA editing endonucleases: KREN1, KREN2, or
KREN3 [4–6]. KREN1 editosomes exclusively contain KREPB8
and exoUase KREX1; KREN2 editosomes exclusively contain
KREPB7; KREN3 editosomes exclusively contain KREPB6. In
addition, these ,20S editosomes contain a common set of proteins
that includes the heterotrimeric [7] insertion subcomplex
(KREPA1, KRET2, and KREL2), the heterotrimeric deletion
subcomplex (KREPA2, KREX2, and KREL1), as well as
KREPA3, KREPA4, KREPA5, KREPA6, KREPB4, and
KREPB5 [8]. Of the two exoUases KREX1 is only in KREN1
editosomes while KREX2 is in the deletion subcomplex of all
three editosomes.
Two components of the ,20S editosome have been shown to
have U-specific exoribonuclease activity: KREX1 and KREX2
[9–11]. A third editosome protein, KREPA3, was also reported to
possess U-specific exoribonuclease activity [12–14] but it contains
no recognizable catalytic motif and deletion editing activity persists
after KREPA3 knockdown [15,16]. Thus, whether KREPA3
performs such a role in vivo is unresolved. RNAi-mediated
knockdown of KREX2 produced no defect in either growth or
editing, but prevented normal association of KREL1 and
KREPA2 with the ,20S editosomes. In contrast, knockdown of
KREX1 resulted in defects in both growth and editing, and
prevented normal association of KREN1 with the ,20S
editosomes. Simultaneous RNAi knockdown of both KREX1
and KREX2 produced greater defects in both growth and editing
than observed by knockdown of KREX1 alone, suggesting that
KREX2 can play a role in RNA editing in vivo.I nT. brucei, both
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ase/phosphatase (EEP) domain (Pfam 03372) with characteristic
conserved catalytic amino acids that indicate that these exonucle-
ases likely have the same catalytic mechanism [17,18]. Notably,
the Leishmania tarentolae KREX2 lacks the EEP domain and does
not have exonuclease activity [10]. Thus, the nature of KREX2
function in RNA editing remains unclear.
RNAi is a useful albeit unpredictable tool in T. brucei. We have
shown that RNAi targeting another editosome protein (KREN3)
produces an insufficient knockdown to reveal its essentiality;
something subsequently demonstrated using the conditional
double knockout approach [4,19]. To unambiguously determine
whether KREX2 is an essential gene, we eliminated both
endogenous KREX2 gene coding sequences by homologous
recombination. We show here using these null mutants that the
KREX2 gene is dispensable in both bloodstream and procyclic
form T. brucei. Procyclic KREX2 null cells exhibit defects in
growth, RNA editing, and editosome sedimentation on glycerol
gradients. Bloodstream form KREX2 null cells exhibit normal
growth, but have defects in RNA editing in vivo as well as
editosome sedimentation on glycerol gradients. Curiously, only a
subset of the phenotypes observed in KREX2 null cells are rescued
by reintroduction of an ectopic KREX2 allele. Purification of
editosomes from KREX2 null cells using TAP-tag fused to either
KREN1 or KREN2 reveals that only editosomes with KREX1
retain exoUase activity in vitro. These results demonstrate that
KREX1 can be sufficient for editing and perhaps functionally
compensate for the loss of KREX2. These results also suggest that
most editing exoUase activity in vivo is catalyzed by KREX1 and
KREX2 has a limited function.
Results
Creation of KREX2 null cells
To create cell lines without KREX2, the endogenous KREX2
alleles were eliminated by homologous recombination in both
bloodstream (BF) and procyclic form (PF) cells. PCR analyses
detect the KREX2 open reading frame in genomic DNA isolated
from parental cells, BF 427 wild-type (wt) or PF 29.13, but not in
derived BF-KREX2-null and PF-KREX2-null cell lines (Figure 1).
In complementary PCR analyses, products corresponding to the
junction of the transgenic knockout constructs in the KREX2
locus are detected in BF-KREX2-null and PF-KREX2-null but
not parental cells. The elimination of KREX2 is also demonstrat-
ed by Southern analysis of BF-KREX2-null cells and Western
analysis of PF-KREX2-null cells (Figure S1).
Growth of KREX2 null cells
Both BF and PF cells grow in the absence of KREX2 expression
(Figure 2). Growth of BF-KREX2-null cells is indistinguishable
from parental 427wt cells in both in vitro culture and in mice.
Growth of PF-KREX2-null cells is slightly slower than parental
29.13 cells in SDM-79 media; however, there is no difference in
growth between these cell lines in the absence of glucose. Growth
after addition of glucose to glucose-free media demonstrates that
the presence of glucose is responsible for the slower growth
phenotype of PF-KREX2-null cells. Curiously, growth of the PF-
KREX2-rDKO cell line (PF-KREX2-null cells transformed by
addition of tetracycline-regulated expression of an ectopic KREX2
allele) is unaltered by tetracycline-induced expression of an ectopic
KREX2 allele, despite evidence that the KREX2 protein is
produced (data not shown, Figure S1).
Editing in vivo
The effect of the loss of KREX2 on editing in vivo was assessed
by quantitative real-time PCR (Figure 3). Comparisons of
mRNAs isolated from BF-KREX2-null and parental BF 427wt
cells revealed that both KREX2 mRNA and edited CYb mRNA
were essentially absent (i.e. not detected) while pre-edited CYb
mRNA accumulated in null cells relative to wild type (Figure 3A).
The abundance of edited COIII and CR3 transcripts was
significantly reduced in null cells relative to wild type, while
edited ND3 was reduced to a lesser extent. Other never-edited,
edited and pre-edited transcripts were similar in abundance in
BF-KREX2-null and wild type cells. Comparisons of mRNAs
from PF-KREX2-null and parental 29.13 cells revealed a profile
that was distinct from BF-KREX2-null cells (Figure 3B). Again,
KREX2 mRNA was not detected in PF-KREX2-null cells.
However, the relative abundance of edited CYb and COIII
mRNAs was essentially the same in null and wild type cells, while
edited CR3, edited ND3, and both edited and pre-edited RPS12
had substantially reduced relative abundance in the null cells, and
edited ND8 was increased. As with BF-KREX2-null cells, the
levels of other never-edited, edited and pre-edited transcripts are
essentially the same in PF-KREX2-null and wild type cells.
KREX1 mRNA abundance in both BF and PF KREX2 null cells
is essentially the same as in wild type cells. Expression of ectopic
KREX2 in the BF-KREX2-rDKO cell line resulted in edited
COIII mRNA levels at normal BF 427wt levels, but the relative
amount of CYb edited mRNA remained unaltered from that in
null cells; KREX2 expression in PF-KREX2-rDKO cells also did
not return the amount of edited ND3 mRNA to wild type levels
(data not shown).
Figure 1. PCR analysis of KREX2 locus demonstrates loss of
KREX2 coding sequence in both BF and PF KREX2 null cells.
KREX2 coding sequence (marked by arrows) is absent in both BF (A.)
and PF (C.) KREX2 null cells (X2null), but present in parental cells (427wt
or 29.13, respectively). Two different primer pairs were used to amplify
either nucleotides (nt) 320–1092 (left panel) or nt 1872–2585 (right
panel) of KREX2 coding sequence. Positive control (+) is a plasmid
containing KREX2 coding sequence. 1 Kb ladder is used as a size
reference. Expected integration of knockout constructs in the KREX2
locus was demonstrated in BF (B.) and PF (D.) KREX2 null cells, but in
not parental cells (427wt or 29.13, respectively). Two different primer
pairs were used to amplify sequence created by intended integration of
first knockout construct (SKO, left panel) or second knockout construct
(DKO, right panel) in KREX2 null cells. Arrows mark expected PCR
products. For BF SKO PCR, one primer anneals in 2 spots, thereby
generating 2 bands.
doi:10.1371/journal.pone.0033405.g001
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PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33405Figure 2. PF KREX2 null cells grow slower than parental cells in vitro, but BF KREX2 null cells grow indistinguishably from parental
cells both in vitro and in vivo. A. Cumulative growth of BF 427wt (solid squares) and derived KREX2 null cells (open squares) in vitro. B. Increasing
parasitemia in 2 mice infected with either BF 427wt (squares) or derived KREX2 null cells (triangles) in vivo. C. Cumulative growth of PF 29.13 (solid
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Editosomes from KREX2 null cells are shifted to lower S values
on glycerol gradients compared to parental cells (Figure 4).
Western analysis shows that ,20S editosomes isolated from BF
427wt peak in fractions 9–11, and that editosomes isolated from
BF-KREX2-null cells are shifted towards fraction 9. The most
obvious evidence of this shift is the increase in KREL1 at the top
of the gradient, consistent with its disrupted association with the
deletion subcomplex. KREL1 is much more prominent in fraction
3 in samples from KREX2-null cells, as observed by both Western
blot and adenylation assay. A more significant shift is observed
with editosomes isolated from PF-KREX2-null cells. The ,20S
editosome peaks in fraction 11 in control 29.13 cells, and shifts to
fraction 9 in PF cells lacking KREX2. As with BF-KREX2-null
cells, PF-KREX2-null cells have a notable increase in KREL1 at
the top of the gradient.
In vitro editing activities in KREX2 null cells
In vitro editing activities are observed in gradient fractions
isolated from both KREX2 null and parental cell lines (Figures 5
and 6). KREX2 null cells maintain the ability to cleave both
insertion and deletion editing site substrates in vitro (Figure 5).
While cleavage activity is restricted to the ,20S peak in fractions
from BF cells, activity extends from ,20S to higher S values in PF,
presumably due to the larger amount of editosome isolated. For
fractions from both BF and PF KREX2 null cells, the amount of
symbols) and derived KREX2 null cells (open symbols) in vitro. In normal SDM-79 media (squares), KREX2 null cells grow more slowly than parental
29.13 cells. In media lacking glucose (triangles) KREX2 null cells grow indistinguishably from parental 29.13 cells. Addition of 6 mM glucose to
glucose-free media re-establishes growth defect of KREX2 null cells (circles).
doi:10.1371/journal.pone.0033405.g002
Figure 3. Real-time PCR analysis of KREX2 null cells. RNA abundance for nuclear mRNAs KREX1 and KREX2 (black bars), never-edited mRNAs
COI and ND4 (light grey bars), pre-edited mRNAs (white bars), and edited mRNAs (dark grey bars) is calculated relative to parental cell line for both BF
(427wt) and PF (29.13). Analysis was performed in triplicate. For each target amplicon, the relative change in RNA abundance was determined by
using either 18S rRNA (left bar in each pair) or b-tubulin (right bar in each pair) as an internal control. Asterisks denote mRNAs that were not detected
in KREX2 null cells. A. A significant loss of CYb editing is shown in BF KREX2 null cells. B. PF KREX2 null cells have predominant decreases in CR3 and
ND3 edited mRNAs.
doi:10.1371/journal.pone.0033405.g003
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fractions. The observed cleavage activities are present in the same
fractions for control parental and derived KREX2 null cells.
KREX2 null cells also maintain U addition, U removal, and ligase
activities as measured by in vitro pre-cleaved editing assays
(Figure 6). In contrast to cleavage activities, pre-cleaved editing
peaks in different fractions in KREX2 null cells, mirroring the
observed shift in editosome proteins towards lower S values. For
both BF and PF control fractions pre-cleaved insertion editing
peaks at fraction 13, while KREX2 null editing peaks in fraction
11 (Figures 6A & B). The shift in pre-cleaved deletion editing for
BF-KREX2-null cells is subtle, most notable by the decrease in
edited product and U-deletion intermediates in fraction 15
compared to parental control (Figure 6C). For PF-KREX2-null
cells, the peak of pre-cleaved deletion is shifted to fractions 9–11
from fraction 13 in control cells, and the overall amount of editing
is decreased in the absence of KREX2 (Figure 6D).
KREX1 removes Us in the absence of KREX2
In vitro U deletion activity is restricted to editosomes that contain
KREX1 in KREX2 null cells (Figure 7). While KREX2 and
KREPA3 are present in all types of editosomes, KREX1 is
restricted to KREN1 editosomes. We therefore isolated KREN1
and KREN2 editosomes from KREX2 null cells to determine
Figure 4. Western and adenylation analyses of glycerol gradient fractionated editosomes from KREX2 null and parental cell lines.
Gradient fractions from BF 427wt (A.), BF-KREX2-null (B.), PF 29.13 (C.) and PF-KREX2-null (D.) were probed using antibodies recognizing editosome
proteins KREPA1, KREPA2, KREL1, and KREPA3 (top panel) or by adenylation of ligases KREL1 and KREL2 (bottom panel). Editosome sedimentation of
KREX2 null samples is shifted toward upper part of the gradient (i.e. smaller in size) relative to parental controls. KREL1 particularly shifts up in the
gradient.
doi:10.1371/journal.pone.0033405.g004
Figure 5. Cleavage activity maintained in KREX2 null cells. Glycerol gradient fractionated editosomes from KREX2 null and parental cell lines
were examined for insertion (A.) or deletion (B.) cleavage activity. Hydroxyl (OH) and T1 nuclease (T1) ladders were used as references. Positive
control reaction using 20S mitochondrial fraction (20S+) requires gRNA (+g) for cleavage, which is absent without gRNA (2g). Arrows denote
cleavage product.
doi:10.1371/journal.pone.0033405.g005
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of KREX2. As expected, KREX1 is found in KREN1 but not
KREN2 editosomes (Figure 7A). The cleavage activity of these
editosomes confirms the expected specificity and functional
capacity of these samples (Figure 7B). To examine U-specific
exonuclease activity of the isolated KREN1 and KREN2
editosomes, samples were tested using a modified pre-cleaved
deletion substrate with a single U replaced by an A (Figure 7C,
top). U-specific exonuclease activity is observed with KREN1
editosomes, but not with KREN2 editosomes in KREX2 null cells
from both BF and PF (Figure 7C, left and right, respectively). In
contrast, both KREN1 and KREN2 editosomes show U-specific
deletion when isolated from PF 29.13 cells. The absence of the -2U
intermediate product is particularly noticeable for KREN2
editosomes isolated from KREX2 null cells.
Discussion
The data we present here demonstrate that KREX2 is not
required for RNA editing, suggesting that U deletion in vivo is
primarily mediated by the subset of editosomes that contain
KREX1. In vitro deletion assays reveal that KREX1 is necessary
for the U-specific exonuclease activity of editosomes isolated from
KREX2 null cells. The loss of KREX2 leads to a smaller
editosome size, as determined by glycerol gradient sedimentation,
and a disruption to the deletion subcomplex, which is apparent by
the shift of KREL1 to lower S value fractions. The abundance of
most edited, pre-edited, and never edited transcripts is unaltered in
KREX2 null cells compared to controls, with distinct exceptions.
Edited CYb is essentially eliminated in BF-KREX2-null cells,
while edited ND3 and edited CR3 are severely decreased in PF-
KREX2-null cells. Regardless of these editing defects, the
persistence of cell growth in the absence of KREX2 in both BF
and PF stages shows that it is not required catalytically or
structurally for editing to occur.
Several lines of evidence indicate that KREX2 has been
eliminated from both BF-KREX2-null and PF-KREX2-null cells.
First, the open reading frame of KREX2 was not detected by two
distinct sets of primers by PCR, while PCR products consistent
with the integrated knockout constructs were found (Figure 1).
Second, Southern analysis of genomic DNA from BF-KREX2-
null cells demonstrates the loss of the KREX2 gene. Third,
Western analysis using anti-KREX2 antibody shows that PF-
KREX2-null cells lack KREX2 protein. Fourth, real-time PCR
analysis shows that KREX2 mRNA is gone in both BF-KREX2-
null and PF-KREX2-null cells. Fifth, the shift in editosome
sedimentation matches independently derived KREX2 RNAi
results. Finally, the loss of U-specific exonuclease activity in
editosomes lacking KREX1 shows the loss of activity consistent
with KREX2. Together these data show that KREX2 has been
eliminated from both BF and PF cells, and thus KREX2 is
dispensable for growth in T. brucei.
While the growth of BF-KREX2-null cells was indistinguishable
from parental control cells both in vivo and in vitro, PF-KREX2-null
cells grew slower than parental 29.13 cells in media containing
glucose (Figure 2). Unlike PF cells BF cells are normally dependent
on glucose. Ectopic expression of KREX2 in the PF null cells,
which was confirmed by Western analysis and resulted in normal
editosome sedimentation but did not rescue normal growth in PF
Figure 6. Pre-cleaved editing assays of glycerol gradient
fractionated editosomes from KREX2 null and parental cell
lines. Editing activities are maintained in KREX2 null cells. 20S glycerol
gradient fraction from purified mitochondria is used as a positive
control. Asterisks in schematics denote location of radiolabel. Pre-
cleaved insertion assays for BF (A.) and PF (B.) demonstrate KREX2 null
cells maintain both TUTase and ligase activity. Pre-cleaved deletion
assays for BF (C.) and PF (D.) demonstrate KREX2 null cells maintain
both exoUase and ligase activity.
doi:10.1371/journal.pone.0033405.g006
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glucose-dependent growth defect in the null cells is coincidental
and unrelated to the loss of KREX2. Alternatively, loss of KREX2
may have resulted in anomalies in mitochondrial function such as
disrupting the balance between oxidative phosphorylation and
glycolysis as implied by the growth deficiency in glucose [20–22].
In this case, differences between ectopic and endogenous
expression may have resulted in the different growth rates. For
example, different rates of protein expression may have altered
editosome assembly, turnover or function.
KREX2 mRNA is absent in null mutant cells but the levels of
KREX1 mRNA and of most edited transcripts are unaltered
compared to parental control cells. However, there are distinct
defects in RNA editing in vivo in BF and PF KREX2 null cells with
effects primarily on Cytochrome mRNAs in BFs and on complex I
mRNAs in PFs. The loss of KREX2 appears to result in transcript-
specific defects in editing. The lack of edited CYb, increased
relative abundance of pre-edited CYb, and ,85% relative
reductions of edited CR3, COIII and ,70% reduction of edited
ND3 mRNA in BF cells is consistent with the normal levels of
these edited mRNAs and their protein products in this life cycle
stage. In particular, edited CYb mRNA, which only has insertion
sites, is normally abundant in PFs and is essentially absent in
slender BFs [23]. In previous experiments, edited CYb was not
detected in BF cells in which transcription of KREN2 or KREPA3
was expressed using a similar conditional knockout system,
suggesting that CYb editing is particularly sensitive to changes to
the editing machinery [15,24]. The rescue in BFs of editing of
COIII but not CYb mRNA upon expression of an ectopic
KREX2 (data not shown) may also reflect the process that controls
the differential editing between life-cycle stages. The substantial
decreases in edited ND3 and CR3 mRNAs and large increase in
edited ND8 mRNAs in PF-KREX2-null cells relative to the
parental cells implies that alterations to complex I are tolerated in
this life cycle stage, which is consistent with previous observations
[25]. The knockdown of both pre-edited and edited RPS12
suggests that aberrant editing of this transcript increases its
turnover rate. The lack of rescue of particular editing defects upon
expression of an ectopic KREX2 gene could reflect a change
unrelated to loss of the KREX2 gene; however, it seems unlikely
that such coincidental defects would specifically disrupt editing of
different mRNAs. Unknown quantitative or qualitative differences
between KREX2 expressed ectopically and KREX2 expressed
from the endogenous locus might compromise its ability to
incorporate into editosomes or function at wild type levels.
The shift of editosomes from both BF and PF null mutants to
lower S values compared to control parental cell lines is consistent
with the loss of KREX2 resulting in structural disruption of the
deletion subcomplex (KREX2/KREPA2/KREL1). The greater
shift of KREL1 compared to KREPA2 may reflect the association
of the latter with KREPA3 and KREPA6 editosome components,
and suggests that KREX2 and KREL1 directly interact [8]. RNAi
knockdown of KREX2 in PF resulted in a similar shift of KREL1,
but not KREPA2, to lower S values [11]. The structural disruption
caused by the loss of KREX2 apparently does not prevent KREL1
function, since KREL1 is essential [26]. Whether KREL1 can
perform its essential function in trans is unknown.
KREX2 null cells maintain the in vitro editing activities present
in parental control cells, but assays of glycerol gradient fractions
reveal clues concerning both KREX2 and editosome function.
While pre-cleaved editing activities are present in KREX2 null
extracts, they are uniformly shifted up toward smaller S values,
mimicking the profile of editosome proteins observed by Western
blot (Figures 4 and 6). In contrast, cleavage activity is observed in
the same fractions from both KREX2 null and parental cells,
namely ,20S and higher (Figure 5). These results suggest that
cleavage activity requires more intact editosomes, i.e. interactions
among multiple proteins, while pre-cleaved activities can be
Figure 7. KREN1 editosomes isolated from KREX2 null cells have exoUase activity, while KREN2 editosomes do not. A. Western
analysis of KREN1 (N1) or KREN2 (N2) TAP purified editosomes from either PF 29.13, BF-KREX2-null, or PF-KREX2-null cells using antibodies
recognizing editosome proteins KREPA1, KREPA2, KREL1, and KREPA3 (top panel) or KREX1 (bottom panel). Note KREX1 signal is restricted to N1
editosomes. B. Expected cleavage specificity observed with KREN1 and KREN2 editosomes isolated from BF-KREX2-null cells. Insertion (top panel) and
deletion (bottom panel) cleavage labeled as in Figure 5. C. Modified pre-cleaved deletion substrate assays U-specific exonuclease activity. Schematic
depicts base change from U to A within the unpaired string of Us typically removed in pre-cleaved deletion assays. Left panel shows that only KREN1
editosomes from BF-KREX2-null cells have U-specific exonuclease activity, while it is possessed by both KREN1 and KREN2 editosomes from PF 29.13.
Right panel shows similar restriction of U-specific exonuclease activity to KREN1 editosomes from PF-KREX2-null cells. Open triangles indicate
increasing amount of extract used in assays. Arrow denotes fully edited product. Note also the lack of -2U product (indicated by black wedges) with
KREN2 editosomes isolated from KREX2 null cells.
doi:10.1371/journal.pone.0033405.g007
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ished editing activities in KREX2 null extracts compared to
parental cells appears largely due to decreased post-cleavage
activities and is consistent with the loss of KREX2 U removal
activity. Thus KREX2 has exonuclease activity in vitro, but
whether it functions as an exonuclease in vivo is unknown given the
functional redundancy of KREX1. Nevertheless, in the absence of
KREX2 U removal in vitro is restricted to editosomes that contain
KREX1 (Figure 7). The presence of KREX1 in editosomes with
deletion site cleavage specificity, combined with the dispensability
of KREX2, suggests that U removal in vivo is primarily done by
KREX1.
What role might KREX2 play in RNA editing in vivo? It could
be an evolutionary relic whose role in U removal activity has been
supplanted by KREX1. The smaller Leishmania KREX2 is
consistent with this possibility, as it lacks the catalytic domain
and hence exoUase activity. KREX2 may have a role in the
structural architecture of the editosome. While this structural role
may not be essential, at least in the laboratory, it may influence
subtle aspects of editosome function such as differential editing
during the life cycle. For example, KREX2 may influence the
interactions of accessory factors with the editosome (Lerch, et al
unpublished). It might also provide a U removal activity in specific
circumstances such as for unusual editing sites from which
numerous Us are removed, or a proofreading activity that
removes excess Us that have been added in error. Hence, KREX2
absence may only be deleterious under conditions where a
substantial decrease in editing fidelity cannot be compensated.
Materials and Methods
Ethics Statement
Trypanosome growth in mice was assessed with the approval of
the Institutional Animal Care and Use Committee at Seattle
Biomedical Research Institute under protocol KS-01. Generation
of transgenic T. brucei cell lines was performed with the approval of
the Institutional Biosafety Committee at Seattle Biomedical
Research Institute under application R1021.
PCR analysis of genomic DNA
PCR was used to determine if the KREX2 coding sequence had
been eliminated by the intended homologous recombinations.
Primer sequences are in Table S1. Two sets of primers were used
to detect two distinct portions of the KREX2 coding sequence;
primers X2for4571 and X2rev3135 amplify nucleotides 320–1092
(773 bp product), while primers X2for3127 and X2rev3177
amplify nucleotides 1872–2585 (714 bp product). Primers that
flank the junction between the inserted knockout construct and the
genomic region 39 of KREX2 were used to amplify products that
demonstrate the intended homologous recombination. Primers
pLEW13for5154 (anneals to two places in pLEW13 insert) and
X2rev3utr5952 generate products of 473 bp and 1811 bp that
indicate integration of the first BF knockout construct. Primers
pLEW90for5209 and X2rev3utr5952 generate a product of
702 bp that indicates integration of the second BF knockout
construct. Primers BSDfor7258 and X2rev3utr5952 generate a
product of 468 bp that indicates integration of the first PF
knockout construct. Primers PACfor3748 and X2rev3utr5952
generate a product of 456 bp that indicates integration of the
second PF knockout construct.
Plasmid constructs
Plasmids pSKO-KREX2 (single knockout) and pDKO-KREX2
(double knockout) were created using published methods to
eliminate both KREX2 alleles in BF cells [26,27], while plasmids
pBSD-KREX2 (single knockout) and pPAC-KREX2 (double
knockout) were created using published methods to eliminate
both KREX2 alleles in PF cells [27–29]. To generate pSKO-
KREX2, the 59 and 39 UTRs of KREX2 were PCR amplified
from 427 genomic DNA using 5FOR-3312, 5REV-3313, 3FOR-
3279, and 3REV-3280 primers. The 313 bp KREX2 59 UTR and
344 bp KREX2 39 UTR PCR products were cloned into the
NotI/MluI and StuI/XbaI sites of pLew13, respectively creating
pSKO-KREX2. pDKO-KREX2 was created by replacing the
SwaI/XhoI fragment (containing Neo
r marker) of pSKO-KREX2
with the 2491 bp StuI/XhoI fragment (containing Hyg
r marker)
from pLew90.
To generate plasmids pBSD-KREX2 and pPAC-KREX2, the
59 and 39 UTRs of KREX2 were PCR amplified from 427
genomic DNA using 5FOR-6519, 5REV-6664, 3FOR-6521, and
3REV-6522 primers. The two PCR products containing 423 bp
KREX2 59 UTR and 344 bp KREX2 39 UTR were then joined
by another PCR amplification to create a single PCR product
flanked by NotI sites and a HindIII, PmeI, and BamHI cloning site
between the 59 and 39 UTRs, as previously described [28,29]. This
PCR product was cloned into the NotI site of pGEM-5Zf(+) vector
(Promega), and the blasticidin (BSD) or puromycin (PAC)
resistance marker (from knockout plasmids targeting TbGPI12
[30] and GPIdeAc [28], respectively) was then inserted between the
UTRs using the HindIII and BamHI sites to create plasmids pBSD-
KREX2 and pPAC-KREX2.
Wild-type KREX2 gene was cloned into the pLEW79 plasmid
[27], creating the pReg-KREX2 plasmid as follows. A 2746 bp
PCR product containing the KREX2 open reading frame was
PCR amplified from 427 genomic DNA with Pfu polymerase using
5orf-3281 and 3orf-3309 primers. The KREX2 ORF was cloned
into the HindIII/BamHI sites of pLEW79. This plasmid was used
to create cell lines with tetracycline-induced expression of an
ectopic KREX2 allele from the rDNA locus.
Cell lines
BF-KREX2-null cell line was generated by a series of
transfections to introduce the pSKO-KREX2 and pDKO-
KREX2 plasmids sequentially into 427 strain cells. First, BF427
cells were transfected with 10 mg NotI-linearized pSKO-KREX2,
and recombinants were selected by G418 resistance. The second
endogenous KREX2 allele was eliminated by transfection with
10 mg NotI-linearized pDKO-KREX2 and subsequent hygromy-
cin selection. Cells were grown in HMI-9 media containing
2.5 mg/ml G418 and 5 mg/ml hygromycin. PF-KREX2-null cell
line was generated by a series of transfections to introduce the
pBSD-KREX2 and pPAC-KREX2 plasmids sequentially into PF
29.13 strain cells [27,31]. First, 29.13 cells were transfected with
10 mg NotI-linearized pBSD-KREX2, and recombinants were
selected by blasticidin resistance. The second endogenous KREX2
allele was eliminated by transfection with 10 mg NotI-linearized
pPAC-KREX2 and subsequent puromycin selection. BF-KREX2-
null cells were grown in HMI-9 media containing 2.5 mg/ml G418
and 5 mg/ml hygromycin. PF-KREX2-null cells were grown in
HMI-9 media containing 15 mg/ml G418, 25 mg/ml hygromycin,
1 mg/ml puromycin, and 10 mg/ml blasticidin. Proper integration
of each plasmid was confirmed by PCR in both BF and PF, as well
as Southern analysis (BF only; Figure S1). TAP-tagged versions of
KREN1 or KREN2 were introduced into both BF and PF
KREX2 null cells using plasmids previously described [5]. A
regulatable ectopic KREX2 allele was subsequently introduced
into the rDNA intergenic locus of both BF-KREX2-null and PF-
KREX2-null cells by transfection with NotI-linearized pReg-
KREX2 Is Not Required in T. brucei
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KREX2-rDKO and PF-KREX2-rDKO cell lines, respectively.
Induction of pReg-KREX2 used 1 mg/ml tetracycline.
Growth of cells in vitro
BF cells were grown in HMI-9 with 10% FBS. PF cells were
grown in SDM-79 with 10% FBS, or in SDM-79 modified by the
removal of glucose and glucosamine with 10% FBS that had been
dialyzed to remove glucose; as noted glucose was returned to
depleted media at final concentration of 6 mM [32]. For each cell
line, cell density was measured by Coulter counter, and
subsequently each culture was reseeded at 2610
5 cells/mL in
10 mL (BF) or at 1610
6 cells/mL in 5 mL (PF).
Growth of cells in vivo. For both BF-427wt and BF-
KREX2-null cell lines, 2.5610
7 total cells from log-phase cultures
grown in HMI-9 with 10% FBS were centrifuged at 1300 g for
10 minutes at room temperature, washed once with 20 mL 16
PBS-G, and then resuspended in 1 mL 16 PBS-G so that the
200 mL injection volume contained 5610
6 cells. For each cell line,
two ,20 g BALB/c mice were infected via intraperitoneal
injection with 5610
6 trypanosomes. Parasitemia was measured
at various time points by tail prick to draw 2 ml of blood that was
preserved in 200 ml of Fixing Solution (3.7% formaldehyde, 16
SSC). The number of trypanosomes was then counted using a
hemocytometer. Mice were killed by CO2 asphyxiation when their
parasitemia neared 1610
9 trypanosomes/mL.
Fractionation of cell lysates on glycerol gradients
Fractionation of BF whole cell lysates on 10–30% glycerol
gradients was performed as previously described [24] with the
following differences: ,1.7610
9 cells were lysed and fractionated
on each gradient, and the gradients were centrifuged at
38,000 rpm in a Beckman SW40 Ti rotor for 8 hours at 4uC.
Briefly, cells were resuspended in lysis buffer (10 mM Tris pH 7.2,
10 mM MgCl2, 100 mM KCl, 1 mM Pefabloc, 2 mg/mL
leupeptin, 1 mg/ml pepstatin, 1 mM DTT) to final volume of
900 mL, and 100 mL 10% Triton X-100 was added. Samples were
mixed by inversion for 15 minutes at 4uC and cleared by two
centrifugation steps of 17,0006 g for 15 minutes at 4uC. After
fractionation, glycerol gradients were divided into 0.5 mL
fractions from the top, flash frozen on liquid nitrogen, and stored
at 280uC. For each sample within an experiment, equivalent cell
numbers were lysed. Fractionation of PF whole cell lysates was
done as for bloodform, except ,4610
9 cells were used. Positive
control ,20S samples from purified PF mitochondria (IsTaR 1.7a
strain) were generated as previously described [24,33].
TAP-tag purifications
Isolation of PF control KREN1 and KREN2 ,20S editosomes
have been previously described [5,6]. Tandem affinity purification
(TAP)wasused toisolateKREN1and KREN2editosomesfromthe
background of KREX2 null cells that had been induced to express
tagged protein by addition of 500 ng/mL tetracycline. Briefly,
equivalent cell numbers (,2.8610
9 cells for BF; ,2610
10 cells for
PF;) were harvested and lysed in 20 mL of IPP150, 1% Triton X-
100, and Complete protease inhibitors (Roche) at 4uC, and then
clarified by centrifugation at 10,0006g. Purification of editosomes
via TAP-tagged KREN1 or KREN2 used sequential IgG and
Calmodulin affinity chromatography as previously described [34].
Western analyses
Glycerol gradient fractions (30 mL) were separated by electro-
phoresis on 10% SDS-PAGE gels, transferred to Immobilon-P
membranes (Fisher), and probed using monoclonal antibodies
against KREPA1, KREPA2, KREL1, and KREPA3 as previously
described [35]. Western analysis of TAP-tag isolated complexes in
Figure 7A was performed using a Licor Odyssey scanner
essentially as previously described [6]. Briefly, samples were
resolved on 10% SDS-PAGE gel, transferred to Immobilon-FL
membranes (LiCor), and blocked in Odyssey blocking buffer. Blots
were simultaneously probed with mouse monoclonal antibodies
against KREPA1, KREPA2, KREL1, and KREPA3 as above,
and 1:2,000 rabbit polyclonal antibody against KREX1 [11]. Blots
were then probed with 1:15,000 IRDye680 conjugated goat anti-
rabbit (LiCor) and IRDye800 conjugated goat anti-mouse (Rock-
land) secondary antibodies and visualized on a LiCor Odyssey
scanner.
In vitro enzymatic assays
For standard pre-cleaved editing and endonuclease cleavage
assays, 15 or 10 mL of glycerol gradient fractions were used,
respectively. Reactions were incubated at 28uC for 3 hours. For all
endonuclease and precleaved assays, RNAs were ethanol precip-
itated, resolved on 11% polyacrylamide 7M urea gels, and
analyzed by PhosphorImager (Molecular Dynamics). A6-derived
substrate assays follow standard protocols described in detail
elsewhere [24,36–38].
A6-derived insertion endonuclease. Cleavage of 70 nt A6-
eES1 pre-mRNA with gA6[14] gRNA was performed as described
[24].
A6-derived deletion endonuclease. Cleavage of 73 nt
A6short/TAG.1 pre-mRNA with D34 gRNA was performed as
described [24].
A6-derived pre-cleaved editing. Standard pre-cleaved
deletion and insertion editing were assayed as previously
described using 59-labeled U5 59CL and U5 39CL with
gA6[14]PC-del and 59-labeled 59CL18 and 39CL13pp with
gPCA6-2A RNAs, respectively [39,40]. For assays with pre-
cleaved deletion substrate U5 59CL3A that is modified to test U
specificity, either 5 or 10 mL of calmodulin eluate from BF samples
or 7 mL from PF samples was assayed as previously described [41].
Real-time PCR analysis
Real-time PCR was performed as previously described, with
values normalized to either 18S rRNA or b-tubulin and an
internal control [4,11,24]. Primers for CR3 and ND8 targets are
in Table S1. Amplicons for these primer sets were sequenced to
confirm they amplified the specified target. For each RNA
measured, the average of three cycle threshold (CT) values was
used in calculations. Relative changes in target amplicons were
determined by using the Pfaffl method, with PCR efficiencies
calculated by linear regression using LinRegPCR [42,43].
Supporting Information
Figure S1 Southern and Western analyses demonstrate
elimination of KREX2 in BF-KREX2-null and PF-
KREX2-null cells. A. Genomic DNA from parental BF-427wt
and derived KREX2 single knockout (SKO) and KREX2-null
(X2null) cell lines was subjected to Southern analysis using a
radiolabeled probe to detect the KREX2 open reading frame
(KREX2 ORF). The band corresponding to KREX2 is present in
DNA from either BF-427wt or BF-KREX2-SKO cell lines, but
completely absent in DNA from BF-KREX2-null cells. B. The
same genomic DNAs used in panel A were also analzyed using a
radiolabeled probe to detect the 39 intergenic region of KREX2.
Hybridization with this probe permits simultaneous detection of
KREX2 Is Not Required in T. brucei
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st allele
KO) with T7 RNA polymerase and Neo
R, and the second allele
knockout (2
nd allele KO) with tetracycline regulator and Hyg
R.
While parental BF-427wt cells have only endogenous KREX2, the
BF-KREX2-null cells lack endogenous KREX2 and only display
hybridization consistent with the knockout constructs that replaced
each KREX2 allele. C. Western analysis of ,20S peak glycerol
gradient fractions from parental PF 29.13 or PF-KREX2-null
(X2null) and derived cells. Anti-KREX2 antibody reveals presence
of KREX2 in 29.13 cells, and absence in PF-KREX2-null cells.
Expression of the tetracycline (tet) regulatable ectopic KREX2
allele in the PF-KREX2-null+KREX2Reg cell line (X2null+X2-
reg) was demonstrated in the presence of tet (+tet), but not in its
absence (2tet). The sizes of proximate marker bands are as
indicated. The amount of KREX2 in extracts from BF cells was
below the limit of detection with this antibody (data not shown).
Southern analysis. Genomic DNA was isolated from each cell
line (ACS protocol). For each cell line, 20 mg of genomic DNA was
digested with either EcoRI or a combination of BamHI and KpnI
and then fractionated by electrophoresis on 0.8% agarose gel.
EcoRI digestion of genomic DNA generates a 1141 bp fragment
(WT), a 5550 bp fragment (first knockout), and and a 2049 bp
fragment (second knockout) detected by NotI probe. BamHI and
KpnI digestion of genomic DNA generates a 4104 bp fragment
(WT) detected by EcoRI probe. Two different DNAs were used as
templates for making radiolabeled probes: an 823 bp EcoRI
fragment of pReg-KREX2 plasmid was used to hybridize to the
KREX2 open reading frame, and a 358 bp XbaI/NotI fragment of
pSKO-KREX2 plasmid was used to hybridize to the 39 intergenic
region of KREX2. Radiolabeled DNA probes were generated
using Ready-To-Go DNA Labeling Beads (GE Healthcare) and
a
32P dCTP according to manufacturer’s protocol. After labeling,
DNA probes were purified using MicroSpin G-25 spin columns
(GE Healthcare) according to manufacturer’s protocol to remove
unincorporated dCTP. KREX2 Western analysis. For each
sample, 30 mL of glycerol gradient fraction 11, corresponding to
,20S peak, was separated by electrophoresis on TGX 10% SDS-
PAGE gels (BioRad), transferred to Immobilon-P membranes
(Fisher), and probed using 1:5 diluted affinity-purified rabbit
polyclonal antibody against KREX2 as previously described [11].
Blot was then probed with 1:2000 goat anti-rabbit conjugated
HRP secondary antibody and visualized by chemiluminescence
(Pierce) detected by x-ray film. PageRuler ladder (Fermentas) was
used as a size marker.
(TIF)
Table S1 Primer sequences used in this study.
(XLS)
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